Exelixis Clinical Site #2

San Antonio, Texas 78229

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Cervical Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Esophageal SCC, Hepatic Impairment, Hormone Receptor-positive Breast Cancer, Immune Sensitive Tumor, Metastatic Castration-resistant Prostate Cancer, Metastatic Solid Tumor, Moderate Hepatic Impairment, Non Small Cell Lung Cancer

Studies at this site

• A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors — Recruiting now
• Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI) — Recruiting now
• Study of XB002 in Subjects With Solid Tumors (JEWEL-101) — Completed